BIOSECURITY TECHNOLOGY, INC.
CIK:0001724001|SEC Filings
Statements of Operations (unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Statements of Operations (unaudited) | ||||
| REVENUE | $ 0 | $ 0 | $ 0 | $ 0 |
| EXPENSES | ||||
| General and Administrative | 93 | 1,084 | 825 | 1,815 |
| Professional | 11,656 | 2,012 | 15,742 | 9,750 |
| Total Expenses | 11,749 | 3,096 | 16,567 | 10,565 |
| Loss from Operations | (11,749) | (3,096) | (16,567) | (10,565) |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| NET LOSS AFTER TAX | $ (11,749) | $ (3,096) | $ (16,567) | $ (10,565) |
| Basic and Diluted Net Loss per Common Share | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Weighted-Average Number of Common Shares Outstanding | 7,120,000 | 7,120,000 | 7,120,000 | 7,120,000 |
Statements of Cash Flows (unaudited) - USD ($) |
6 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| CASH FLOWS FROM OPERATING ACTIVITES: | ||
| Net Loss After Tax | $ (16,567) | $ (10,565) |
| Changes in Operating Assets and Liabilities: | ||
| Accounts Receivable | 0 | 0 |
| Prepaid Expenses | 66 | (94) |
| Accounts Payable | (92) | (99) |
| Net Cash from Operating Activities | (16,593) | (10,758) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceed from Related Party Loan | 18,001 | 168 |
| Proceeds from Sale of Common Shares | 0 | 0 |
| Net Cash from Financing Activities | 18,001 | 168 |
| Net Increase (Decrease) in Cash | 1,408 | (10,590) |
| Cash, Beginning of Period | 3,937 | 15,106 |
| Cash, End of Period | 5,345 | 4,516 |
| Cash Paid for: | ||
| Interest | 0 | 0 |
| Income Taxes | $ 0 | $ 0 |
Balance Sheets - USD ($) |
Dec. 31, 2020 |
Jun. 30, 2020 |
|---|---|---|
| Current Assets | ||
| Cash | $ 5,345 | $ 3,937 |
| Accounts Receivable | 0 | 0 |
| Prepaid expenses | 0 | 66 |
| Total Current Assets | 5,345 | 4,003 |
| Total Assets | 5,345 | 4,003 |
| Current Liability | ||
| Accounts Payable | 99 | 191 |
| Due to Related Party | 49,432 | 31,431 |
| Total Liabilities | 49,531 | 31,622 |
| Stockholders' Equity (Deficit) | ||
| Common Stock, $0.001 par value, 75,000,000 shares authorized; 7,120,000 and 7,120,000 shares issued and outstanding | 7,120 | 7,120 |
| Additional paid in capital | 19,080 | 19,080 |
| Retained Earnings (Deficit) | (70,386) | (53,819) |
| Total Stockholders' Equity (Deficit) | (44,186) | (27,619) |
| Total Liabilities and Stockholders' Equity (Deficit) | $ 5,345 | $ 4,003 |